InsideArbitrage Event Driven Monitor – February 10, 2025
Merger Arbitrage
- SWI: The acquisition of SolarWinds Corporation (SWI) by Turn/River Capital, for a closing value of $4.4 billion. Under the terms of the agreement, SolarWinds will be acquired by Turn/River Capital in an all-cash transaction for $18.50 per share. (Press Release)
- BALY: The acquisition of Bally’s Corporation (BALY) by Standard General was completed on February 7, 2025. It took 197 days for the deal to be completed.
- MRNS: Immedica Pharma announced that it has completed its tender offer to purchase all outstanding shares of common stock of Marinus Pharmaceuticals (MRNS) for $0.55 per share. The tender offer expired on February 6, 2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
